Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Practically Speaking: Olanzapine to manage cancer related anorexia.

  • Broadcast in Medicine
MedOncNow

MedOncNow

×  

Follow This Show

If you liked this show, you should follow MedOncNow.
h:2444437
s:12221561
archived

To be added to the distribution list, please email: DDeCastro@southlakeregional.org

In this episode, Dr. Sharlene Gill will discuss the incorporation of Olanzapine into clinic to help manage anorexia and cancer related weight loss.

Key Opinion Leader: 

Dr. Sharlene Gill

Professor of Medicine, UBC
Medical Oncologist, BC Cancer - Vancouver
Chair, GI Disease Site, Canadian Cancer Trials Group
Chair, BC Cancer Medical Advisory Committee
President, Canadian Association of Medical Oncologists

Host:
Dr. Shaqil Kassam 
skassam@southlakeregional.org
Medical Oncologist
Stronach Regional Cancer Centre, Newmarket, Ontario 

Outline:
0:00 - Introduction
1:40 – Dr. Sharlene Gill Introduction
3:20 – Current anorexia management strategies.
5:20 - Olanzapine as a new S.O.C. for B.S.C
6:40 - Extrapolation of the data to a Canadian Population
14:30- Implementation in a Canadian practice
27:00 - Patient profile appropriate for Olanzapine. 

 

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled